FDA Approves Drug to Slow Progression of Rare Form of MND

FDA Approves Drug to Slow Progression of Rare Form of MND

The Food and Drug Administration (FDA) in the US has authorised the drug, formerly known as Tofersen, which helps to slow down the progression of a